Safety and Efficacy of Autologous Skeletal Myoblast Sheets (TCD-51073) for the Treatment of Severe Chronic Heart Failure Due to Ischemic Heart Disease.
about
Designing 3D Mesenchymal Stem Cell Sheets Merging Magnetic and Fluorescent Features: When Cell Sheet Technology Meets Image-Guided Cell Therapy.Smooth muscle cell sheet transplantation preserve cardiac function and minimize cardiac remodeling in a rat myocardial infarction model.Potential Strategies to Address the Major Clinical Barriers Facing Stem Cell Regenerative Therapy for Cardiovascular Disease: A Review.Ethical and Regulatory Challenges with Autologous Adult Stem Cells: A Comparative Review of International Regulations.Femoral nerve block with propofol sedation versus general anesthesia in patients with severe cardiac dysfunction undergoing autologous myoblast sheet transplantation.Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue.Tooth extraction in a patient after autologous skeletal myoblast sheet transplantation for severe dilated cardiomyopathy.An invention of thermo-responsive polymer surface, yielding cell sheet based regenerative therapies in cardiology and ophthalmology.Myocardial regenerative therapy using a scaffold-free skeletal-muscle-derived cell sheet in patients with dilated cardiomyopathy even under a left ventricular assist device: a safety and feasibility study.Myocardial Tissue Engineering for Regenerative Applications.Improved clinical course of autologous skeletal myoblast sheet (TCD-51073) transplantation when compared to a propensity score-matched cardiac resynchronization therapy population.State-of-the-Art in Tissue-Engineered Heart RepairAccelerating regenerative medicine: the Japanese experiment in ethics and regulation.Concerns on a new therapy for severe heart failure using cell sheets with skeletal muscle or myocardial cells from iPS cells in Japan.Effect of Temperature Changes on Serum Protein Adsorption on Thermoresponsive Cell-Culture Surfaces Monitored by A Quartz Crystal Microbalance with Dissipation.
P2860
Q35972352-7ACB175D-E32D-4E73-B184-C9F1301F8EC3Q37154181-56DB1875-63A7-497B-B716-3999420E5C95Q37735796-EF49744A-4138-4293-874D-C6F2CF99827DQ38372717-87E4E468-0DB6-4455-B637-C320A66E7537Q38728386-42B78F31-0718-48E7-A858-88FB808F8B8AQ38874116-396BA52A-769E-494D-9E4C-9AACD74768EBQ40322746-F042B5E8-07D8-4D63-B6BA-9AB4B3DFEBA2Q42695555-46880D5B-1F3B-4F4A-B99D-65E30B8A8ED5Q47777508-CA095EF4-C2DD-4EDE-9974-2E7C47C78F20Q47871478-DCB8910E-B45C-4E6D-93D7-AAC026F2913CQ48030100-23FD32CD-30C0-4DDF-93C8-6F2DA7D7BA8FQ48774892-F406AB41-ADA1-494F-BE16-7C323083D49AQ49613181-A8CEB3A9-6D8A-4AA0-92C8-4CEF349E4FA3Q52629143-D8BC06D1-9735-45C8-9B56-1D56021E1FA0Q55230773-0C5E98BF-8406-4A37-B739-6629CDE9EB88
P2860
Safety and Efficacy of Autologous Skeletal Myoblast Sheets (TCD-51073) for the Treatment of Severe Chronic Heart Failure Due to Ischemic Heart Disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Safety and Efficacy of Autolog ...... Due to Ischemic Heart Disease.
@en
Safety and Efficacy of Autologous Skeletal Myoblast Sheets
@nl
type
label
Safety and Efficacy of Autolog ...... Due to Ischemic Heart Disease.
@en
Safety and Efficacy of Autologous Skeletal Myoblast Sheets
@nl
prefLabel
Safety and Efficacy of Autolog ...... Due to Ischemic Heart Disease.
@en
Safety and Efficacy of Autologous Skeletal Myoblast Sheets
@nl
P2093
P356
P1433
P1476
Safety and Efficacy of Autolog ...... Due to Ischemic Heart Disease.
@en
P2093
Kenji Yamazaki
Koichi Toda
Koichiro Kinugawa
Minoru Ono
Nobuhisa Hagiwara
Satsuki Fukushima
Shigeru Miyagawa
Yasushi Sakata
Yasushi Yoshikawa
Yoshiki Sawa
P304
P356
10.1253/CIRCJ.CJ-15-0243
P577
2015-01-01T00:00:00Z